Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02TQA
|
|||
| Former ID |
DNC009768
|
|||
| Drug Name |
N-Hydroxy-E-3-(4'-chlorobiphenyl-4-yl)-acrylamide
|
|||
| Synonyms |
CHEMBL557066; SCHEMBL3292989; SCHEMBL3292983; BDBM50293365
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H12ClNO2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C=CC(=O)NO)C2=CC=C(C=C2)Cl
|
|||
| InChI |
1S/C15H12ClNO2/c16-14-8-6-13(7-9-14)12-4-1-11(2-5-12)3-10-15(18)17-19/h1-10,19H,(H,17,18)/b10-3+
|
|||
| InChIKey |
GBZPSEMNRBQROD-XCVCLJGOSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Design, synthesis, and evaluation of biphenyl-4-yl-acrylohydroxamic acid derivatives as histone deacetylase (HDAC) inhibitors. Eur J Med Chem. 2009 May;44(5):1900-12. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.